BlueCrest Capital Management »

Regeneron Pharmaceuticals shares owned by BlueCrest Capital Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by BlueCrest Capital Management from 13F filings

Historical chart of BlueCrest Capital Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by BlueCrest Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by BlueCrest Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $350k 425 822.96
2018-09-30 $1.1M 2.7k 404.06
2016-03-31 $1.1M 3.0k 360.38

More positions owned by BlueCrest Capital Management

Spdr Gold Tr Gold Shs (GLD)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr S&p 100 Etf (OEF)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
PG&E Corporation (PCG)
Alphabet Cap Stk Cl A (GOOGL)
Crocs Call Option (CROX)
Spdr Series Trust S&p Oilgas Exp (XOP)
Amazon (AMZN)
Kraneshares Trust Csi Chi Internet (KWEB)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Meta Platforms Cl A (META)
Ishares Ethereum Tr SHS (ETHA)

View all positions for BlueCrest Capital Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Goldman Sachs Group
Nuveen
Northern Trust

View all funds holding Regeneron Pharmaceuticals